CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the Bernstein Strategic Decisions Conference 2011 on Wednesday, June 1, 2011 at 2:00 p.m. EDT and at the Goldman Sachs 32nd Annual Global Healthcare Conference on Tuesday, June 7, 2011 at 2:40 p.m. PDT (5:40 p.m. EDT).
The presentations will be webcast live and may be accessed from ‘Events & Presentations’ on the home page of Vertex’s website at www.vrtx.com. A replay of the webcasts will also be available on the Company’s website for two weeks following the presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
Vertex creates new possibilities in medicine. Our team aims to discover, develop and commercialize innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, epilepsy and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada.
Vertex’s press releases are available at www.vrtx.com.
Lora Pike, 617-444-6755
Director, Investor Relations
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Health Biotechnology Infectious Diseases Oncology Pharmaceutical